NanoLogix Inc. Stock Analysis NNLX
NanoLogix, Inc. is a biotechnology company, which engages in the research, development, commercialization, and production of filled Petri plates and rapid diagnostic test kits that detect viable bacteria and other microorganisms. The company is headquartered in Hubbard, Ohio. The company went IPO on 2001-07-20. The firm's key areas of interest are Bio Nanopores, Anthrax Detections, Petri Dishes, Highly Specializeds, Permeables, Membranes, Translucents, Nutrients, Nutrient Agars, Impermeable Cells, Hydrophilics, Isolation, Cultivations, Varieties, Fastidious, Nonfastidious, Anaerobic Microogranisms, Total Plate Counts, Biotechnology, Detect Viable Bacteria, Petri Culture Technology, Cleanrooms, Quick Tests, Mrsas, Group B Streps, Salmonellas, Listerias, Single Cells. The firm was founded in 1989.
Read More NanoLogix Inc (NNLX) Chart
Financial Metrics & Statements of NanoLogix Inc (NNLX)
FAQ's for NanoLogix Inc (NNLX)
- According to Musaffa’s Shariah screening methodology, NanoLogix Inc (NNLX) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.